IMMK Literatur

 Hier mal eine Liste von IMMK Literatur, leider ist nicht alles öffentlich zugänglich:

• O. Kershaw et al.: Detection of equine herpesvirus type 2 (EHV-2) in horses with keratoconjunctivitis. Virus Res. Vol. 80 (1-2; 2001).

• K. Borchers et al.: Prevalence of equine herpesvirus type 2 (EHV-2) DNA in ocular swabs and its cell tropism in equine conjunctiva. Vet Microbiol. Vol. 118 (3-4; 2006).

• A. Metthews & B.C. Gilger: Equine immune-mediated keratopathies. Vet Ophthalmol. Vol. 12 (1; 2009).

• J. Toth et al.: Clinical experience and long-term outcome after subscleral insertion of a cyclosporine A drug delivery device in horses with immune-mediated keratitis. Pferdeheilkunde. Vol. 27 (6; 2011).

• D.O. Pate at al.: Immunohistochemical and immunopathologic characterization of superficial stromal immune-mediated keratitis in horses. Am J Vet Res. Vol. 73 (7; 2012).

• J.O. Rushton et al.: Detection of equid herpesviruses 2 and 5 in a herd of 266 Lipizzaners in association with ocular findings. Vet Microbiol. Vol. 164 (1-2; 2013).

• F. Sonderegger at al.: Die Prävalenz von EHV-2 und EHV-5 bei Pferden mit Keratokonjunktivitis und augengesunden Pferden in der Schweiz. Pferdeheilkunde. Vol. 29 (4; 2013).

• M. Padjasek et al.: PLDLA/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses. Int J Mol Sci. Vol. 24 (26 2023).

• K.E. Knickelbein & M.E. Lassaline: Approach to Immune-mediated Ocular Diseases. Vet Clin North Am Equine Pract. Vol. 40 (2; 2024).

• F. Narinx et al.: Subconjunctival autologous muscle-derived mesenchymal stem cell therapy: A novel, minimally invasive approach for treating equine immune-mediated keratitis. Vet Ophthalmol. Vol. 27 (5; 2024).

• J.F. Preston et al.: Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland: 94 cases (2009-2021). Equine Vet J. Vol. 57 (3; 2025)